Article
Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.
Neuron - 2 Oct 2013
Saxena Smita, Roselli Francesco, Singh Katyayani, Leptien Kerstin, Julien Jean-Pierre, Gros-Louis Francois, Caroni Pico
Abstract excerpt
Delaying clinical disease onset would greatly reduce neurodegenerative disease burden, but the mechanisms influencing early preclinical progression are poorly understood. Here, we show that in mouse models of familial motoneuron (MN) disease, SOD1 mutants specifically render vulnerable MNs dependent on endogenous neuroprotection signaling involving excitability and mammalian target of rapamycin (mTOR). The most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
